EphA2 overexpression causes tumorigenesis of mammary epithelial cells
- PMID: 11280802
EphA2 overexpression causes tumorigenesis of mammary epithelial cells
Abstract
Elevated levels of protein tyrosine phosphorylation contribute to a malignant phenotype, although the tyrosine kinases that are responsible for this signaling remain largely unknown. Here we report increased levels of the EphA2 (ECK) protein tyrosine kinase in clinical specimens and cell models of breast cancer. We also show that EphA2 overexpression is sufficient to confer malignant transformation and tumorigenic potential on nontransformed (MCF-10A) mammary epithelial cells. The transforming capacity of EphA2 is related to the failure of EphA2 to interact with its cell-attached ligands. Interestingly, stimulation of EphA2 reverses the malignant growth and invasiveness of EphA2-transformed cells. Taken together, these results identify EphA2 as a powerful oncoprotein in breast cancer.
Similar articles
-
Antibody targeting of the EphA2 tyrosine kinase inhibits malignant cell behavior.Cancer Res. 2002 May 15;62(10):2840-7. Cancer Res. 2002. PMID: 12019162
-
Differential EphA2 epitope display on normal versus malignant cells.Cancer Res. 2003 Nov 15;63(22):7907-12. Cancer Res. 2003. PMID: 14633720
-
EphA2 overexpression decreases estrogen dependence and tamoxifen sensitivity.Cancer Res. 2003 Jun 15;63(12):3425-9. Cancer Res. 2003. PMID: 12810680
-
Diverse roles for the Eph family of receptor tyrosine kinases in carcinogenesis.Microsc Res Tech. 2002 Oct 1;59(1):58-67. doi: 10.1002/jemt.10177. Microsc Res Tech. 2002. PMID: 12242697 Review.
-
Protein kinases in mammary gland development and cancer.Microsc Res Tech. 2002 Oct 1;59(1):49-57. doi: 10.1002/jemt.10176. Microsc Res Tech. 2002. PMID: 12242696 Review.
Cited by
-
EphA2 super-enhancer promotes tumor progression by recruiting FOSL2 and TCF7L2 to activate the target gene EphA2.Cell Death Dis. 2021 Mar 12;12(3):264. doi: 10.1038/s41419-021-03538-6. Cell Death Dis. 2021. PMID: 33712565 Free PMC article.
-
EPHA2 is a mediator of vemurafenib resistance and a novel therapeutic target in melanoma.Cancer Discov. 2015 Mar;5(3):274-87. doi: 10.1158/2159-8290.CD-14-0295. Epub 2014 Dec 26. Cancer Discov. 2015. PMID: 25542448 Free PMC article.
-
Insights on the Functional Role of Beta-Glucans in Fungal Immunity Using Receptor-Deficient Mouse Models.Int J Mol Sci. 2021 Apr 30;22(9):4778. doi: 10.3390/ijms22094778. Int J Mol Sci. 2021. PMID: 33946381 Free PMC article. Review.
-
Proteolytic Cleavage of Receptor Tyrosine Kinases.Biomolecules. 2021 Apr 29;11(5):660. doi: 10.3390/biom11050660. Biomolecules. 2021. PMID: 33947097 Free PMC article. Review.
-
Identification of therapeutic targets and prognostic biomarkers of the ephrin receptor subfamily in pancreatic adenocarcinoma.J Int Med Res. 2024 Jan;52(1):3000605231218559. doi: 10.1177/03000605231218559. J Int Med Res. 2024. PMID: 38180878 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous